2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Blood Screening Market?

The escalating occurrence of infectious diseases is predicted to drive the growth of the blood screening market in the future. Blood is frequently examined for signs of disease by searching for a unique antibody produced against the infectious pathogen. This assists medical professionals in managing infectious diseases and halting further transmission of infection among patients and person-to-person contamination. For example, the National Center for Biotechnology Information, a government agency based in the US, reported in June 2022 that the occurrence of infectious diseases in outpatient care has nearly tripled in the last two decades, going up from 8 to 26 per 1,000. Consequently, the surge in the occurrence of infectious diseases is fueling the expansion of the blood screening market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

#What is the Growth Potential of the Blood Screening Market, and How Will It Perform by 2034?

Over the past few years, the size of the blood screening market has seen a robust growth. It is expected that this market will expand from $3.15 billion in 2024 to $3.45 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The exponential growth during the historic period is credited to factors like a surge in the necessity for blood transfusions, escalated occurrence of communicable diseases, government norms and standards, an upswing in blood donations and collection, and global health concerns, including pandemics.

Anticipated to witness a significant surge in the forthcoming years, the blood screening market is projected to escalate to $5.37 billion by 2029, advancing at a composite annual growth rate (CAGR) of 11.7%. The projected growth during the forecast period is speculated to be driven by enhancements in healthcare infrastructure, public health enlightenment initiatives, progress in the diagnostics of infectious diseases, global health apprehensions, and readiness for pandemics. The forecast period will experience substantial trends such as increase in infectious diseases, enhanced automation and efficiency, proliferating demands for blood transfusions, emphasis on ensuring safety in transfusions, and ongoing research in pathogen detection.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

What New Market Trends Are Reshaping theBlood Screening Market and Its Opportunities?

Leading businesses within the blood screening market are introducing advancements like liquid biopsy to better early cancer identification, enhance the monitoring of treatments, and facilitate personalized treatment methods. Liquid biopsy refers to a minimally invasive examination that scrutinizes blood or other body fluids to discover cancer cells or genetic material from tumors. To illustrate, in November 2023, Guardant Health, Inc., a biotech firm based in the US, rolled out the Shield blood-based screening tests. These tests examine cell-free DNA (cfDNA) present in the bloodstream, a potential marker of colorectal tumors or precancerous formations. They specifically search for changes in DNA fragments, which can be shed into the blood by cancer cells.

Who Are the Leading Market Players Fueling Growth in the Blood Screening Market Trend?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

How is the Global Blood Screening Market Segemented?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smpGlobal Blood Screening Market, Global Blood Screening Market Report, Global Blood Screening Market Trends, Global Blood Screening Market Size

Browse Through More Reports Similar to the Gobal Blood Screening Maret 2025, By The Business Research Company:

Analytical Laboratory Instrument Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Group Typing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: